ATHIRA PHARMA INC's ticker is ATHA and the CUSIP is 04746L104. A total of 106 filers reported holding ATHIRA PHARMA INC in Q2 2022. The put-call ratio across all filers is 0.31 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $39,000 | 0.0% | 13,008 | +0.7% | 0.02% | +14.3% |
| Q2 2022 | $39,000 | -75.0% | 12,914 | +11.7% | 0.01% | -80.0% |
| Q1 2022 | $156,000 | -2.5% | 11,561 | -5.6% | 0.07% | +16.7% |
| Q4 2021 | $160,000 | +55.3% | 12,249 | +11.8% | 0.06% | +33.3% |
| Q3 2021 | $103,000 | -12.7% | 10,956 | -5.0% | 0.04% | -8.2% |
| Q2 2021 | $118,000 | – | 11,530 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VR Adviser, LLC | 1,691,623 | $31,126,000 | 3.38% |
| ACUTA CAPITAL PARTNERS, LLC | 400,000 | $7,360,000 | 2.65% |
| Logos Global Management LP | 1,010,812 | $18,599,000 | 1.82% |
| S Squared Technology, LLC | 181,220 | $3,334,000 | 1.58% |
| Avidity Partners Management LP | 1,677,845 | $30,872,000 | 0.85% |
| Perceptive Advisors | 3,425,916 | $63,037,000 | 0.80% |
| RTW INVESTMENTS, LP | 2,652,553 | $48,807,000 | 0.76% |
| Sofinnova Investments, Inc. | 509,168 | $9,369,000 | 0.56% |
| HighVista Strategies LLC | 32,062 | $590,000 | 0.44% |
| DAFNA Capital Management LLC | 91,531 | $1,684,000 | 0.40% |